1. Market Research
  2. > Pathology Industry

carcinoma Industry, April 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Hepatitis, Renal Cancer, Cancer, Therapy, Lung Cancer, Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Cervical Cancer, Computed Tomography, Health Care Provider, Bladder Cancer, Cancer Diagnostic, DNA, Dermatological Condition, Digestive System Disorder, Molecular Diagnostic, Prostate Cancer, Sexually Transmitted Disease.


 
1-10 of 98 reports for carcinoma

Purchase Reports From Reputable Market Research Publishers

The 2018-2023 World Outlook for Renal Cell Carcinoma (RCC) Drugs

The 2018-2023 World Outlook for Renal Cell Carcinoma (RCC) Drugs

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for renal cell carcinoma (RCC) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

  • $ 2500
  • Industry report
  • April 2017
  • by RNCOS

Hepatocellular carcinoma (HCC), also called malignant hepatoma, is the most common type of liver cancer. Most cases of HCC result either from infection with viral hepatitis (Hepatitis B or C), metabolic ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • March 2017
  • by GlobalData

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical ...

Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023

Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Renal cell carcinoma- Market Insights, Epidemiology and Market Forecast-2023

Renal cell carcinoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Renal cell carcinoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

Renal cell carcinoma - Epidemiology Forecast To 2023

Renal cell carcinoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Renal cell carcinoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Renal cell carcinoma in seven major markets (US, France, Germany, Italy, Spain, ...

Neuroendocrine Carcinoma - Epidemiology Forecast To 2023

Neuroendocrine Carcinoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Neuroendocrine Carcinoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Neuroendocrine Carcinoma in seven major markets (US, France, Germany, Italy, ...

Europe Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017

Europe Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017
  • by Fore Pharma

Fore Pharma announced the results of its Hepatocellular Carcinoma patients study in a new report ‘Europe Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides ...

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017
  • by Fore Pharma

Fore Pharma announced the results of its Renal Cell Carcinoma patients study in a new report ‘Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

Global Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017

Global Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017
  • by Fore Pharma

Fore Pharma announced the results of its Hepatocellular Carcinoma patients study in a new report ‘Global Hepatocellular Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides ...

About 6800 reports for carcinoma

Download Unlimited Documents from Trusted Public Sources

Sexually Transmitted Disease Statistics and Cancer Statistics in the Netherlands

  • March 2017
    213 pages
  • Sexually Transm...  

    Cancer  

    Smoking Statist...  

  • Netherlands  

    Europe  

View report >

Cancer Statistics

August 2016

Cancer Statistics

June 2015

Cancer Statistics

August 2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.